Medicure Inc (MCUJF) — 6-K Filings

6-K Filings (21)

• MEDICURE INC. Files November 2025 6-K Report — Nov 19, 2025 Risk: low
  On November 19, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of November 2025 and indicates that MEDICURE INC. is a foreign p
• 6-K Filing — Nov 14, 2025
• MEDICURE INC. Files August 2025 6-K Report — Aug 21, 2025 Risk: low
  On August 21, 2025, MEDICURE INC. filed a Form 6-K for the month of August 2025. The company, headquartered at 1250 Waverley Street, Winnipeg, MB Canada R3T 6C6
• MEDICURE INC. Files June 2025 6-K Report — Jun 18, 2025 Risk: low
  On June 17, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of June 2025 and indicates that the company is a foreign private iss
• MEDICURE INC. Q1 2025 Results: Revenue $33.78M, Net Loss $3.38M — May 21, 2025 Risk: medium
  MEDICURE INC. reported its Q1 2025 results for the period ending March 31, 2025. The company had total revenue of $33,775,000 and a net loss of $3,375,000 for t
• MEDICURE INC. Files Form 6-K with SEC — Apr 28, 2025 Risk: low
  On April 25, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of April 2025 and indicates that the company is a foreign private i
• MEDICURE INC. Files Form 6-K — Apr 23, 2025 Risk: low
  On April 23, 2025, MEDICURE INC. filed a Form 6-K with the SEC, reporting for the month of April 2025. The company is a foreign private issuer based in Winnipeg
• MEDICURE INC. Files April 2025 6-K Report — Apr 11, 2025 Risk: low
  On April 11, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of April 2025 and indicates that the company is a foreign private i
• MEDICURE INC. Files March 2025 6-K Report — Mar 12, 2025 Risk: low
  On March 12, 2025, MEDICURE INC. filed a Form 6-K report for the month of March 2025. The company, based in Winnipeg, Canada, is a foreign private issuer and is
• MEDICURE INC. Files February 2025 6-K Report — Feb 18, 2025 Risk: low
  On February 18, 2025, MEDICURE INC. filed a Form 6-K report for the month of February 2025. The company, headquartered in Winnipeg, MB, Canada, is a foreign pri
• MEDICURE INC. Files November 2024 6-K Report — Nov 26, 2024 Risk: low
  On November 26, 2024, MEDICURE INC. filed a Form 6-K with the SEC, reporting information for the month of November 2024. The company, based in Winnipeg, Canada,
• MEDICURE INC. Files October 2024 6-K Report — Nov 18, 2024 Risk: low
  On October 24, 2024, MEDICURE INC. filed a Form 6-K with the SEC, reporting its activities for the month of October 2024. The company, based in Winnipeg, Canada
• MEDICURE INC. Files October 6-K Report — Oct 25, 2024 Risk: low
  On October 25, 2024, MEDICURE INC. filed a Form 6-K for the month of October 2024. The company, based in Winnipeg, Canada, is a pharmaceutical preparations manu
• MEDICURE INC. Files August 2024 6-K Report — Aug 26, 2024 Risk: low
  On August 26, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private
• MEDICURE INC. Files August 2024 6-K Report — Aug 15, 2024 Risk: low
  On August 15, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private
• MEDICURE INC. Files August 2024 6-K Report — Aug 14, 2024 Risk: low
  On August 14, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private
• Medicure Inc. Signs New Agreement, Files 6-K — Jun 25, 2024 Risk: low
  On June 24, 2024, Medicure Inc. announced the signing of a new agreement. The company, headquartered at 2-1250 Waverley Street in Winnipeg, MB Canada, filed a F
• Medicure Inc. Files 6-K with Financial Results — May 29, 2024 Risk: low
  On May 28, 2024, Medicure Inc. filed a Form 6-K report. The filing includes a news release announcing their financial results. Dr. Albert D. Friesen, CEO, signe
• Medicure's MC-302 Gets FDA Fast Track for Psoriasis — Apr 26, 2024 Risk: medium
  On April 23, 2024, Medicure Inc. announced that it received U.S. FDA Fast Track designation for its drug candidate, MC-302, for the treatment of moderate to sev
• Medicure Inc. Files 6-K with Financial Results — Apr 8, 2024 Risk: low
  On April 8, 2024, Medicure Inc. filed a Form 6-K report with the SEC. This report includes a news release detailing their financial results for the period endin
• Medicure Inc. Files 6-K, Announces Financial Results Presentation — Apr 5, 2024 Risk: low
  On April 4, 2024, Medicure Inc. filed a Form 6-K report with the SEC. The filing includes a news release announcing that the company will present its financial

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX